The AI Revolution in Healthcare

The AI revolution has begun. It is starting to see its impact in many facets of the health care and health innovation ecosystem. We are seeing their impact in the way innovation occurs, how health care is delivered and the way we make clinical and business decisions.

Join us on November 21 as we explore real-life examples of ongoing uses and the people behind these game-changing AI innovations. This panel will explore uses in drug development, healthcare delivery, and business decision making. We will touch on aspects of challenges and opportunities in the AI space, how development really occurs and the opportunity for commercialization.

Date: Thursday, November 21, 2024
Time: 6:00 – 9:00 p.m.
Location: Leslie Dan Faculty of Pharmacy

SOLD OUT! - Register for the waitlist

Select a drop-down to learn more.

Mina Tadrous

Mina Tadrous

1T5 PhD
Assistant Professor, Leslie Dan Faculty of Pharmacy

Professor Tadrous is a licensed pharmacist and pharmacoepidmeiologist. He has developed an impactful research program that has helped change drug policies in Ontario and nationally, and has earned a reputation as a respected teacher and mentor. He leads research in the Faculty’s clinical, social and administrative pharmaceutical sciences division, using real-world evidence to improve how medications are used. He works with policymakers and large data sets to answer questions about medication safety and effectiveness. Professor Tadrous also has research appointments at Women’s College Hospital, ICES and the Ontario Drug Policy Research Network.

Dr. Mina Tadrous’ research focus on two main areas of interest: post-marketing real-world evidence of medications’ utilization and pharmaceutical policy. He is keenly interested in using and developing advanced pharmacoepidemiologic methods to study the safety, effectiveness, and utilization of drugs to inform clinical practice and policy.

Professor Tadrous’s research has helped inform policies that improve access to critical medications, including chronic hepatitis B therapeutics. As a teacher, mentor and preceptor, Professor Tadrous said he has two main goals — giving his students opportunities to practice making evidence-based decisions and exposing them to non-traditional pharmacy career paths and opportunities. Students have selected him for two teaching awards: a Professor of the Year Award in 2018, and an APPE Preceptor of the Year Award in 2021.

Christine Allen

Christine Allen

Professor, Leslie Dan Faculty of Pharmacy
Co-Founder and CEO, Intrepid Labs

Dr. Christine Allen is a world-renowned and award-winning researcher, experienced leader and entrepreneur. Dr. Allen is a Full Professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto (U of T) where she has had a stellar 20+ year career as a researcher and entrepreneur. She is a globally renowned expert in drug formulation and development with more than 160 publications to her name and numerous successful collaborations with clinical and industry partners. She is co-founder and former president of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy (featured by Scientific American as one of 10 start-ups changing healthcare). She also served as CSO of a biotech company and regularly collaborates with, and serves as an advisor to biotech and pharmaceutical companies.

During her time at U of T, she has held increasingly senior leadership roles, most recently as inaugural Associate Vice-President and Vice-Provost, Strategic Initiatives (2019 – 2022). She has also held senior leadership roles outside of academia, including most recently as the Vice-President Ecosystem Development at adMare Bioinnovations (2022 – 2023, one year leave from U of T). Dr. Allen is active in a range of scientific societies and has served on their boards, and most recently as President of the Controlled Release Society (CRS, 2022 – 2023) and President of the Canadian Society for Pharmaceutical Sciences (CSPS, 2020 – 2022). She also served as a member on the Governing Council of the Natural Sciences and Engineering Research Council of Canada for four years (first term 2018 – 2020; second term 2020 – 2022). She spent 10 years as a journal editor. First, as an Associate Editor at the American Chemical Society journal Molecular Pharmaceutics then as an Associate Editor at the Journal of Controlled Release, and finally as the Editor-in-Chief of the Journal of Controlled Release.

Dr. Allen is a fellow of the American Institute for Medical and Biological Engineering, a fellow of CRS, a fellow of the CSPS and a fellow of the Canadian Academy of Health Sciences.

Muhammad Mamdani

 

Muhammad Mamdani

Professor, Leslie Dan Faculty of Pharmacy
Vice-President, Data Science and Advanced Analytics, Unity Health Toronto

Dr. Mamdani is a Professor cross-appointed to the Dalla Lana School of Public Health, Leslie Dan Faculty of Pharmacy, and Temerty Faculty of Medicine at the University of Toronto. Dr. Mamdani earned his PharmD at the University of Michigan in 1995. He then graduated with a MA in Econometric Theory in 1997 at Wayne State University. He pursued an MPH in Research Methodology and Quantitative Methods at Harvard University which he completed in 1998.

Dr. Mamdani has held various professional employment positions at the Institute for Clinical Evaluative Sciences (ICES), Pfizer, and St. Michael's Hospital in Toronto. Most recently, Dr. Mamdani has held the positions of Adjunct Senior Data Scientist at Institute for Clinical Evaluative Sciences since 2007, Director of Li Ka Shing Centre for Healthcare Analytics Research and Training (LKS-CHART) at St. Michael's Hospital since 2016, and Vice President of Data Science and Advanced Analytics at Unity Health Toronto since 2019. Under an academic setting, Dr. Mamdani has also held Faculty Affiliate status at the University of Toronto's Vector Institute in addition to the position of Director at the University of Toronto's Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM).

Dr. Mamdani established the Applied Health Research Centre (AHRC) at St. Michael's Hospital, the Li Ka Shing Centre for Healthcare Analytics Research and Training (LKS-CHART), and the Ontario Drug Policy Research Network (ODPRN). To enhance patient outcomes and hospital productivity, Dr. Mamdani's team integrates modern analytics, including machine learning, with management and clinical decision-making. In order to exploit advancements in data analytics to improve patient care, he has been working with engineers, statisticians, physicians, computer scientists, and administrators at St. Michael's Hospital as part of his research. To estimate patient volume, staffing demands, and patient needs, the team has created deep-learning algorithms that leverage real-time data.

Peter Zhang

Peter Zhang

2T8 PhD (c), 2T2 MBA, 2T1 PharmD, 1T7 BSc
Business Acceleration Partner, ODAIA
Clinical Pharmacist, Southlake Regional Health Centre

Dr. Zhang is a hospital pharmacist, technology professional, and PhD student at the Leslie Dan Faculty of Pharmacy at the University of Toronto. His research explores the journey of clinician entrepreneurs and seeks to inform educational interventions that lower the barrier of entry to entrepreneurship for healthcare professionals. An avid writer, Dr. Zhang’s works have appeared in research journals, such as BMJ Global Health, and in national news outlets in Canada such as the Toronto Star, the Globe and Mail, and the National Post.

Professionally, Dr. Zhang is a Business Acceleration Partner at ODAIA Intelligence, a health tech company that leverages artificial intelligence to optimize engagements between pharmaceutical companies and physicians with the goal of reducing patients’ time to therapy. Previously, Dr. Zhang worked as a Marketing Manager for Johnson & Johnson in their pharmaceutical business unit where he built prediction machines for commercial teams. He also sits on the Board of Directors of Hemophilia Ontario and he practices as a hospital pharmacist at Southlake Regional Health Centre in Newmarket.